Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Gordon

Showing results (81-90 of 234) with videos related to

Pageof 24
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Lupus nephritis management guidelines comparedSuzanne Wilhelmus, Ingeborg M Bajema, George K Bertsias, et al.
Arthritis and Rheumatism|May 29, 2007
Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid jointLakhvir K Assi, See Heng Wong, Andreas Ludwig, et al.
Pharmacoeconomics|September 4, 2023
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology AppraisalThomas Otten, Rob Riemsma, Ben Wijnen, et al.
Arthritis Care & Research|August 5, 2015
Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus RegistryLaura Plantinga, S Sam Lim, Rachel Patzer, et al.
BMJ Open|July 23, 2013
Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysisNgianga-Bakwin Kandala, Martin Connock, Amy Grove, et al.
BMJ Open|December 19, 2019
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trialAlexis Jones, Patrick Muller, Caroline J Dore, et al.
Arthritis and Rheumatism|November 13, 2002
A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et alMatthew J Simmonds, Joanne M Heward, M Ann Kelly, et al.
Rheumatology International|October 26, 2020
'But you don't look sick': a qualitative analysis of the LUPUS UK online forumMelanie Sloan, Michael Bosley, Moira Blane, et al.
Rheumatology Advances in Practice|February 19, 2021
The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal studyMelanie Sloan, Caroline Gordon, Rupert Harwood, et al.
Arthritis and Rheumatism|January 31, 2002
Candidate T cell epitopes of the human La/SSB autoantigenMarie L Davies, Emma J Taylor, Caroline Gordon, et al.
Pageof 24

Showing results (81-90 of 234) with videos related to

Sort By:
Pageof 24
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Lupus nephritis management guidelines comparedSuzanne Wilhelmus, Ingeborg M Bajema, George K Bertsias, et al.
Arthritis and Rheumatism|May 29, 2007
Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid jointLakhvir K Assi, See Heng Wong, Andreas Ludwig, et al.
Pharmacoeconomics|September 4, 2023
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology AppraisalThomas Otten, Rob Riemsma, Ben Wijnen, et al.
Arthritis Care & Research|August 5, 2015
Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus RegistryLaura Plantinga, S Sam Lim, Rachel Patzer, et al.
BMJ Open|July 23, 2013
Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysisNgianga-Bakwin Kandala, Martin Connock, Amy Grove, et al.
BMJ Open|December 19, 2019
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trialAlexis Jones, Patrick Muller, Caroline J Dore, et al.
Arthritis and Rheumatism|November 13, 2002
A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et alMatthew J Simmonds, Joanne M Heward, M Ann Kelly, et al.
Rheumatology International|October 26, 2020
'But you don't look sick': a qualitative analysis of the LUPUS UK online forumMelanie Sloan, Michael Bosley, Moira Blane, et al.
Rheumatology Advances in Practice|February 19, 2021
The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal studyMelanie Sloan, Caroline Gordon, Rupert Harwood, et al.
Arthritis and Rheumatism|January 31, 2002
Candidate T cell epitopes of the human La/SSB autoantigenMarie L Davies, Emma J Taylor, Caroline Gordon, et al.
Pageof 24